AstraZeneca announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort? Maintenance And Reliever Therapy (Symbicort SMART?). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms.
When talking about nutrition, EGCG and probiotics are two words that we’ve been hearing a lot about these days. But most consumers don’t know what they are, where they are found and what they do. Some of that mystery was cleared up this week at the 47th Annual Symposia of the American College of Nutrition (ACN) where leading nutrition experts revealed new research about the health benefits of these two ingredients.
The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis, according to a team of researchers at the Stanford University School of Medicine. Their findings will be published in the October issue of the Journal of Clinical Investigation.
Every day we are exposed to external toxins from our environment and internal toxins produced as the byproduct of our digestive and metabolic processes. Toxic and unwanted inorgranic chemicals are found in our foods, water and air in the form of fertilizers, pesticides, heavy metals and other pollutants.
The Food and Drug Administration today approved Remicade (infliximab) to treat children with active Crohn’s disease, a chronic, inflammatory condition of the bowel that can be severely debilitating. Remicade is a genetically engineered monoclonal antibody, which reduces inflammation (swelling/redness) by blocking the action of tumor necrosis factor-alpha (TNF-a), that was initially approved in 1998 to treat Crohn’s disease in adults.
People with chest pain that’s not caused by a heart condition or heartburn may find hypnosis provides significant pain relief and improves their sense of general well-being, British investigators report.
The Food and Drug Administration (FDA) announced approval of Sutent (sunitinib), a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors (GIST), a rare stomach cancer, and advanced kidney cancer. This action marks the first time the agency has approved a new oncology product for two indications simultaneously.
Buccal drug delivery pioneer, Generex, is expanding its diabetes treatment pipeline to include a new metformin chewing gum that aims to avoid the significant adverse gastrointestinal side-effects often accompanying the use of metformin tablets.
A University of Washington psychologist in Seattle says some overweight people’s ability to exercise may be hampered by gastrointestinal problems.
Type 0 glycogen storage disease (GSD 0) is caused by a deficiency in glycogen synthase, an enzyme critical for adequate glycogen synthesis. As a result, there is a marked decrease in glycogen stores resulting in fasting hypoglycemia and post-prandial hyperglycemia. Dietary carbohydrates are preferentially converted to lactate.